Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immutep (IMMP) Cash & Equivalents (2016 - 2025)

Immutep filings provide 12 years of Cash & Equivalents readings, the most recent being $47.8 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 1.15% to $47.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.8 million, a 1.15% decrease, with the full-year FY2025 number at $43.2 million, down 59.51% from a year prior.
  • Cash & Equivalents hit $47.8 million in Q4 2025 for Immutep, up from $43.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $106.6 million in Q2 2024 to a low of $43.2 million in Q2 2025.
  • Median Cash & Equivalents over the past 5 years was $52.8 million (2022), compared with a mean of $61.7 million.
  • Biggest five-year swings in Cash & Equivalents: soared 170.46% in 2021 and later plummeted 59.51% in 2025.
  • Immutep's Cash & Equivalents stood at $72.6 million in 2021, then crashed by 38.12% to $44.9 million in 2022, then soared by 50.32% to $67.5 million in 2023, then fell by 28.45% to $48.3 million in 2024, then dropped by 1.15% to $47.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $47.8 million (Q4 2025), $43.2 million (Q2 2025), and $48.3 million (Q4 2024) per Business Quant data.